- Home
- INTU vs ABT Comparison
INTU vs ABT Comparison
Compare INTU & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTU
- ABT
- Stock Information
- Founded
- INTU 1983
- ABT 1888
- Country
- INTU United States
- ABT United States
- Employees
- INTU N/A
- ABT N/A
- Industry
- INTU Computer Software: Prepackaged Software
- ABT Medical/Dental Instruments
- Sector
- INTU Technology
- ABT Health Care
- Exchange
- INTU Nasdaq
- ABT Nasdaq
- Market Cap
- INTU 213.2B
- ABT 237.4B
- IPO Year
- INTU 1993
- ABT N/A
- Fundamental
- Price
- INTU $783.61
- ABT $133.65
- Analyst Decision
- INTU Buy
- ABT Buy
- Analyst Count
- INTU 20
- ABT 18
- Target Price
- INTU $801.65
- ABT $140.44
- AVG Volume (30 Days)
- INTU 1.5M
- ABT 5.7M
- Earning Date
- INTU 08-21-2025
- ABT 07-17-2025
- Dividend Yield
- INTU 0.53%
- ABT 1.76%
- EPS Growth
- INTU 13.03
- ABT 139.92
- EPS
- INTU 12.24
- ABT 7.70
- Revenue
- INTU $18,184,000,000.00
- ABT $42,344,000,000.00
- Revenue This Year
- INTU $17.45
- ABT $7.56
- Revenue Next Year
- INTU $12.43
- ABT $7.73
- P/E Ratio
- INTU $64.03
- ABT $17.36
- Revenue Growth
- INTU 14.99
- ABT 5.00
- 52 Week Low
- INTU $532.65
- ABT $99.71
- 52 Week High
- INTU $790.60
- ABT $141.23
- Technical
- Relative Strength Index (RSI)
- INTU 66.50
- ABT 48.42
- Support Level
- INTU $765.81
- ABT $132.71
- Resistance Level
- INTU $784.54
- ABT $137.08
- Average True Range (ATR)
- INTU 11.73
- ABT 2.62
- MACD
- INTU -2.36
- ABT -0.18
- Stochastic Oscillator
- INTU 82.62
- ABT 27.48
About INTU Intuit Inc.
Intuit serves small and midsize businesses with accounting software QuickBooks and online marketing platform Mailchimp. The company also operates retail tax filing tool TurboTax, personal finance platform Credit Karma, and a suite of professional tax offerings for accountants. Founded in the mid-1980s, Intuit enjoys a dominant market share for small business accounting and do-it-yourself tax filing in the US.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.